Table 3A. Efficacy data (study population; N=39).
| N | % | |
|---|---|---|
| ORR | 7 | 18 |
| CR | 0 | 0 |
| PR | 7 | 18 |
| SD | 22 | 56 |
| PD | 10 | 26 |
| Median PFS | 3.5 months (1.9-10.1) | |
| Median OS since start of cetuximab | 11.1 months (1.9-74.0) | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.